NDC 0088-2502
Apidra SoloStar
Insulin Glulisine
Apidra SoloStar is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Insulin Glulisine.
| Product ID | 0088-2502_286b7639-8fe3-4fbd-928f-a4fde7746f43 |
| NDC | 0088-2502 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Apidra SoloStar |
| Generic Name | Insulin Glulisine |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2009-02-24 |
| Marketing Category | BLA / NDA |
| Application Number | BLA021629 |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | INSULIN GLULISINE |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |